Health Care/Hospital News & Press Release Distribution

Health Care/Hospital

APAC
Global

C-Ray Therapeutics Receives Radiopharmaceutical Manufacturing Authorization under China's MAH Framework

CHENGDU, China, June 25, 2026 /PRNewswire/ -- On June 23, 2026, C-Ray Therapeutics (Chengdu) Co., Ltd. ("C-Ray Therapeutics") completed on-site inspections conducted by a panel of experts from the Sichuan Provincial Center for Drug Evaluation and the National Defense Science and Industry Adminis...

2026-06-25 11:33 7597

Dimora Medical has joined the NPIAP Corporate Advisory Council as an Honorary Member

NEW YORK, June 24, 2026 /PRNewswire/ -- Dimora Medical, a continuous innovator in high-end medical care supplies, has officially joined the National Pressure Injury Advisory Panel (NPIAP) as a corporate member, marking a new step in its engagement with the global clinical community focused on pre...

2026-06-25 11:24 9100

Dimora Medical has joined the NPIAP Corporate Advisory Council as an Honorary Member

ATLATL and Samsung Bioepis Launch 'Samsung Bioepis Innovation Prize C-Lab Outside' to Accelerate Early-Stage Biotech Innovation Across Asia-Pacific

Applications Open June 25 for Early-Stage Biotech Companies Developing Next-Generation Therapeutics and Platform Technologies SHANGHAI, June 25, 2026 /PRNewswire/ -- ATLATL Innovation Center ("ATLATL"), a global innovation platform for life science research and development, and Samsung Bioepis C...

2026-06-25 07:30 9439

ATLATL and Samsung Bioepis Launch 'Samsung Bioepis Innovation Prize C-Lab Outside' to Accelerate Early-Stage Biotech Innovation Across Asia-Pacific

Abu Dhabi Announces Partnership with MSD to Advance Operational Excellence and Expand Access across the Region

ABU DHABI, UAE, June 25, 2026 /PRNewswire/ -- As healthcare systems worldwide seek more resilient and efficient pathways to deliver innovative medicines, the Department of Health – Abu Dhabi (DoH) has announced a collaboration with global pharmaceutical leader MSD (Merck & Co., Inc., Rahway, New...

2026-06-25 03:15 8994

Abu Dhabi Announces Partnership with MSD to Advance Operational Excellence and Expand Access across the Region

NYSE Content Update: Abridge Partners with Eli Lilly, Nvidia to Improve Healthcare

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, June 24, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begin...

2026-06-24 21:18 8774

NYSE Content Update: Abridge Partners with Eli Lilly, Nvidia to Improve Healthcare

HKeyBio Debuts HKEY-ExE™ 1.0 to Address Preclinical Bottlenecks in EoE and EgE Drug Development

The EoE-centered framework supports disease modeling, multidimensional efficacy endpoints, type 2 biomarker analysis, and cross-indication translational research BOSTON and SUZHOU, China, June 24, 2026 /PRNewswire/ -- HKeyBio, a preclinical contract research organization focused on autoimmune an...

2026-06-24 21:18 6648

Metabolon Delivers Large-Scale Metabolomics Dataset to Genomics England's 100,000 Genomes Project to Advance Rare Disease Research

Dataset from more than 7,500 participants expands multiomic analysis in rare disease research by combining metabolomics with genomic and clinical data MORRISVILLE, N.C., June 24, 2026 /PRNewswire/ -- Metabolon, Inc., the global leader in metabolomics solutions advancing life science research, dia...

2026-06-24 21:00 5617

Frost & Sullivan: Aileen.ai Receives the 2026 North American Transformational Innovation Leadership Recognition for Advancing Relationship-Based AI-Enabled Senior Care

The company's innovative AI health companion enhances continuity of care through scalable, relationship-based support for older adults SAN ANTONIO, June 24, 2026 /PRNewswire/ -- Frost & Sullivan

2026-06-24 21:00 5581

HKeyBio Launches NHP Fast-Tox Program for Accelerating Non-GLP NHP Safety Risk Screening

The program supports early tolerability assessment, PK/TK-linked safety evaluation, immune-related risk screening, and pre-GLP dose design for biologics and immunomodulatory drug programs BOSTON and SUZHOU, China, June 24, 2026 /PRNewswire/ -- HKeyBio, a preclinical CRO focused on autoimmune and...

2026-06-24 20:36 6160

IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine

* IMU's AI platform unlocks unprecedented immune insights for cancer and other diseases, measuring 100M+ data points from a single blood sample, analyzed in real time. * Waters Biosciences' technologies, including BD FACSDiscover™ and BD Rhapsody™ Instruments, will be used with IMU's AI analy...

2026-06-24 20:00 6982

Tarek Samad appointed EVP, Head of Research & Development at Lundbeck

VALBY, Denmark, June 24, 2026 /PRNewswire/ -- H. Lundbeck A/S (Lundbeck) today announced that Tarek Samad has been appointed Executive Vice President and Head of Research & Development (R&D) and will join the Executive Leadership Team (ELT) effective 1 September 2026. Tarek Samad succeeds Johan ...

2026-06-24 18:19 8287

Ping An Good Doctor CEO He Mingke Speaks At 2026 Summer Davos: China Is Entering Its Own "Longevity Era"

HONG KONG and SHANGHAI, June 24, 2026 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. ("Ping An" or the "Group"; HKEX: 2318/82318; SSE: 601318) attended the World Economic Forum's 17th Annual Meeting of the New Champions, also known as Summer Davos 2026, convened at the Dalian I...

2026-06-24 17:58 11816

Ping An Good Doctor CEO He Mingke Speaks At 2026 Summer Davos: China Is Entering Its Own

Yidu Tech's Gong Yingying at Summer Davos: Building Evidence Infrastructure to Expand Access to Innovative Medicines

DALIAN, China, June 24, 2026 /PRNewswire/ -- On June 23, at the 17th Annual Meeting of the New Champions (Summer Davos 2026) hosted by the World Economic Forum in Dalian, Gong Yingying, Founder and Chairlady of Yidu Tech, participated in the panel discussion "Faster Drugs, Better Access?". She sh...

2026-06-24 17:30 8566

World's First Solid Tumor CAR-T Approved: Jiahui International Cancer Center Provides Access for Patients Worldwide

SHANGHAI, June 24, 2026 /PRNewswire/ -- Jiahui International Cancer Center (JICC) welcomes the approval of Satri-cel (CT041, Kaileimei®), the world's first CAR-T cell therapy approved for the treatment of a solid tumor, marking a historic milestone in cancer care and opening new possibilities for...

2026-06-24 17:01 6113

Lundbeck presents new Vyepti® (eptinezumab) and bocunebart migraine portfolio data at EAN 2026

* Five migraine presentations will showcase Lundbeck's current and future approaches to migraine prevention, including new data for eptinezumab and Phase IIb PROCEED primary data for the investigational treatment, bocunebart * Eptinezumab data explore patient-centered outcomes in chronic migra...

2026-06-24 16:08 5698

Everest Medicines and Hainan Herui have entered into a commercialization collaboration relating to Hainan Herui's budesonide enteric capsules

SHANGHAI, June 24, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that Everest Medicines and Hainan He...

2026-06-24 15:07 8424

DuPont Launches Tyvek® APX™ in ASEAN Market

Enhanced breathability without compromising protection or durability helps improve wearer comfort in demanding work environments BANGKOK, June 24, 2026 /PRNewswire/ -- DuPont (NYSE:DD) today announced it has launched Tyvek® APX™ in the ASEAN market at Thailand Safe@Work 2026 in Bangkok. Through ...

2026-06-24 15:00 7418

DuPont Launches Tyvek® APX™ in ASEAN Market

WuXi Biologics' 25th Drug Substance Facility Completes First GMP Production, Manufacturing Process Execution with Zero Deviations

SHANGHAI, June 24, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that its MFG17 drug substance facility located at the Shanghai Fengxian site has successfully completed its first GMP production camp...

2026-06-24 14:39 7603

Milliken Expands Innovation Capabilities with New Polymer Solutions Pilot Plant in Pune, India

Facility strengthens ability to accelerate development and scale advanced materialsolutions for global markets. PUNE, India, June 24, 2026 /PRNewswire/ -- Milliken & Company has opened a new state of the art pilot plant facility in Pune, India, further strengthening its polymer solutions busine...

2026-06-24 14:24 6126

UniXell Biotechnology Secures FDA IND Clearance for UX-DA003, Achieving China-U.S. Dual Breakthrough in iPSC Parkinson's Therapy

SHANGHAI, June 23, 2026 /PRNewswire/ -- UniXell Biotechnology Co., Ltd. ("UniXell") has secured Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for UX-DA003, its allogeneic induced pluripotent stem cell (iPSC)-derived therapy for Parkinson's disease. Pair...

2026-06-24 14:04 5602

1 ... 49 50 515253 54 55 ... 845